Literature DB >> 19411858

Genomic sequence matters: a SNP in microRNA-146a can turn anti-apoptotic.

Krystian Jazdzewski, Albert de la Chapelle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411858      PMCID: PMC4348695     

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  16 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.

Authors:  Teng Xu; Ying Zhu; Qing-Kun Wei; Yunfei Yuan; Fan Zhou; Yi-Yuan Ge; Jian-Rong Yang; Hang Su; Shi-Mei Zhuang
Journal:  Carcinogenesis       Date:  2008-08-18       Impact factor: 4.944

3.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.

Authors:  D Bhaumik; G K Scott; S Schokrpur; C K Patil; J Campisi; C C Benz
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

5.  Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB.

Authors:  Chih-Yuan Wang; Wen-Bin Zhong; Tien-Chun Chang; Shu-Mei Lai; Yuan-Feen Tsai
Journal:  Cancer       Date:  2002-11-01       Impact factor: 6.860

6.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

7.  Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.

Authors:  Francesco Pacifico; Claudio Mauro; Ciro Barone; Elvira Crescenzi; Stefano Mellone; Mario Monaco; Gennaro Chiappetta; Giuseppe Terrazzano; Domenico Liguoro; Pasquale Vito; Eduardo Consiglio; Silvestro Formisano; Antonio Leonardi
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

8.  Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells.

Authors:  Dmitriy Starenki; Hiroyuki Namba; Vladimir Saenko; Akira Ohtsuru; Shunichi Yamashita
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

9.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.

Authors:  Krystian Jazdzewski; Sandya Liyanarachchi; Michal Swierniak; Janusz Pachucki; Matthew D Ringel; Barbara Jarzab; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells.

Authors:  Mark M Perry; Sterghios A Moschos; Andrew E Williams; Neil J Shepherd; Hanna M Larner-Svensson; Mark A Lindsay
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more
  14 in total

Review 1.  MicroRNAs in thyroid cancer.

Authors:  Albert de la Chapelle; Krystian Jazdzewski
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

2.  Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).

Authors:  Krystian Jazdzewski; Joanna Boguslawska; Jaroslaw Jendrzejewski; Sandya Liyanarachchi; Janusz Pachucki; Kazimierz A Wardyn; Alicja Nauman; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

Review 3.  MicroRNAs as biomarkers in rheumatic diseases.

Authors:  Ilias Alevizos; Gabor G Illei
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

Review 4.  miRNAs in the pathogenesis of oncogenic human viruses.

Authors:  Zhen Lin; Erik K Flemington
Journal:  Cancer Lett       Date:  2010-10-12       Impact factor: 8.679

Review 5.  Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review.

Authors:  Yang Yang; Xiajun Shi; Zhengxun Du; Gendong Zhou; Xiaohong Zhang
Journal:  Herz       Date:  2021-12-08       Impact factor: 1.443

6.  Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.

Authors:  Anna Wójcicka; Małgorzata Czetwertyńska; Michał Świerniak; Joanna Długosińska; Monika Maciąg; Agnieszka Czajka; Kinga Dymecka; Anna Kubiak; Adam Kot; Rafał Płoski; Albert de la Chapelle; Krystian Jażdżewski
Journal:  Genes Chromosomes Cancer       Date:  2014-03-06       Impact factor: 5.006

7.  In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.

Authors:  Michal Swierniak; Anna Wojcicka; Malgorzata Czetwertynska; Elzbieta Stachlewska; Monika Maciag; Wieslaw Wiechno; Barbara Gornicka; Magdalena Bogdanska; Lukasz Koperski; Albert de la Chapelle; Krystian Jazdzewski
Journal:  J Clin Endocrinol Metab       Date:  2013-06-19       Impact factor: 5.958

Review 8.  Single-nucleotide polymorphisms among microRNA: big effects on cancer.

Authors:  Feng-Ju Song; Ke-Xin Chen
Journal:  Chin J Cancer       Date:  2011-06

Review 9.  MicroRNA-related sequence variations in human cancers.

Authors:  A Wojcicka; A de la Chapelle; K Jazdzewski
Journal:  Hum Genet       Date:  2013-11-19       Impact factor: 4.132

10.  A SNP in pri-miR-10a is associated with recurrent spontaneous abortion in a Han-Chinese population.

Authors:  Ying Li; Xue-Qin Wang; Lu Zhang; Xiao-Dan Lv; Xing Su; Shi Tian; Chun-Mei Liu; Xu Ma; Hong-Fei Xia
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.